Gynecological diseases like uterine fibroids can seriously impact a woman's feeling of well-being and quality of life as well as pose an economic burden for healthcare systems.
Uterine Fibroids (UF) are smooth muscle tumors of the uterus and are the most common gynecological tumor.
48% of women with UF report having no knowledge of UF before diagnosis. A lack of clinical guidance adds to diagnosis and treatment delays.
Globally, there is no long-term, non-invasive, fertility and uterus-sparing treatment for UF. Bayer is therefore investing in this field as part of its clinical development program.
Each body reacts differently to medicines. Therefore it is impossible to tell which medicine works best for you. Please consult your physician.